These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 25701774)
1. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. Boriani G; Manolis AS; Tukkie R; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; Gulizia M; Samoilenko IV; Wolff C; Holbrook R; Gavazza F; Padeletti L; Heart Rhythm; 2015 Jun; 12(6):1192-200. PubMed ID: 25701774 [TBL] [Abstract][Full Text] [Related]
2. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G; Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753 [TBL] [Abstract][Full Text] [Related]
3. Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial. de Sousa J; Marques P; Martins V; Hipólito-Reis A; Duarte L; Joaquim I; Monteiro D; Boriani G; Wolff C; Grammatico A; Padeletti L Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):973-978. PubMed ID: 30528686 [TBL] [Abstract][Full Text] [Related]
4. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L; Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721 [TBL] [Abstract][Full Text] [Related]
5. Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial. Boriani G; Tukkie R; Biffi M; Mont L; Ricci R; Pürerfellner H; Botto GL; Manolis AS; Landolina M; Gulizia M; Hudnall JH; Mangoni L; Grammatico A; Padeletti L; Heart Rhythm; 2017 Oct; 14(10):1476-1484. PubMed ID: 28506917 [TBL] [Abstract][Full Text] [Related]
6. Prevention of long-lasting atrial fibrillation through antitachycardia pacing in DDDR pacemakers. Boriani G; Sakamoto Y; Botto G; Komura S; Pieragnoli P; Minamiguchi H; Iacopino S; Noma T; Infusino T; Takahashi Y; Facchin D; De Rosa F; Pisanò E; Meloni S; Biffi M Int J Clin Pract; 2021 Mar; 75(3):e13820. PubMed ID: 33164319 [TBL] [Abstract][Full Text] [Related]
7. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial. Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270 [TBL] [Abstract][Full Text] [Related]
8. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L; Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124 [TBL] [Abstract][Full Text] [Related]
9. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ; Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388 [TBL] [Abstract][Full Text] [Related]
10. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study. Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M; Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300 [TBL] [Abstract][Full Text] [Related]
11. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945 [TBL] [Abstract][Full Text] [Related]
12. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE; J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559 [TBL] [Abstract][Full Text] [Related]
13. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA; Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566 [TBL] [Abstract][Full Text] [Related]
14. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Botto GL; Ricci RP; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Garutti C; Vainer L; Kozák M; Heart Rhythm; 2014 Jun; 11(6):992-1000. PubMed ID: 24418164 [TBL] [Abstract][Full Text] [Related]
15. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation. Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208 [TBL] [Abstract][Full Text] [Related]
16. Programming Pacemakers to Reduce and Terminate Atrial Fibrillation. Pujol-López M; San Antonio R; Tolosana JM; Mont L Curr Cardiol Rep; 2019 Sep; 21(10):127. PubMed ID: 31520271 [TBL] [Abstract][Full Text] [Related]
17. Management of atrial fibrillation in bradyarrhythmias. Boriani G; Padeletti L Nat Rev Cardiol; 2015 Jun; 12(6):337-49. PubMed ID: 25781413 [TBL] [Abstract][Full Text] [Related]
18. [Clinical Value of Algorithms of Minimization of Right Ventricular Pacing in Patients With Sick Sinus Syndrome and History of Atrial Fibrillation]. Ivanchina AE; Kopylov FY; Volkova AL; Samojlenko IV; Syrkin AL Kardiologiia; 2018 Aug; (8):58-63. PubMed ID: 30131043 [TBL] [Abstract][Full Text] [Related]
19. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy. Deniz HB; Caro JJ; Ward A; Moller J; Malik F J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):43-50. PubMed ID: 18268418 [TBL] [Abstract][Full Text] [Related]
20. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study. Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S; Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]